CD8A and ovarian cancer: Karapetsas A et al. have reported that GPC-6 may function as a predictive indicator of CD8+ T-lymphocyte infiltration and a favorable prognostic index in early-stage ovarian cancer, showing significant clinical value in diagnosis, prognosis, and tumor immunobattling [55].